Henry Carl Nisser - 14 Jun 2021 Form 3 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role: Exec VP and General Counsel, Director
Signature: /s/ Henry Nisser
Issuer symbol: ALZN
Transactions as of: 14 Jun 2021
Net transactions value: $0
Form type: 3
Filing time: 14 Jun 2021, 19:55:47 UTC
Next filing: 24 Aug 2021
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ALZN	Options							14 Jun 2021	Common Stock	1,250,000	$1.50	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of the Issuer's Common Stock issuable upon the exercise of stock options (the "Options"), which are currently exercisable. Mr. Nisser was granted Options to purchase 1,250,000 shares of the Issuer's Common Stock, which Options vest ratably over four (4) years beginning on June 1, 2019. The Options are exercisable for a period of five (5) years at an exercise price of $1.50 per share. Of these Options, 677,083 shares of Common Stock are currently vested and exercisable.

Content

Represents shares of the Issuer's Common Stock issuable upon the exercise of stock options (the "Options"), which are currently exercisable. Mr. Nisser was granted Options to purchase 1,250,000 shares of the Issuer's Common Stock, which Options vest ratably over four (4) years beginning on June 1, 2019. The Options are exercisable for a period of five (5) years at an exercise price of $1.50 per share. Of these Options, 677,083 shares of Common Stock are currently vested and exercisable.